BiotechTube

olmesartan medoxomil + Placebo + losartan potassium

ApprovedCompleted
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Hypertension

Conditions

Hypertension

Trial Timeline

Aug 1, 2009 → Jan 1, 2010

NCT ID
NCT00949884

About olmesartan medoxomil + Placebo + losartan potassium

olmesartan medoxomil + Placebo + losartan potassium is a approved stage product being developed by Daiichi Sankyo for Hypertension. The current trial status is completed. This product is registered under clinical trial identifier NCT00949884. Target conditions include Hypertension.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00949884ApprovedCompleted

Competing Products

20 competing products in Hypertension

See all competitors
ProductCompanyStageHype Score
macitentan 10 mgBML, Inc.Phase 3
76
tadalafil + tadalafilEli LillyPhase 3
77
CS1 AdministrationCereno ScientificPhase 2
47
CS1Cereno ScientificPre-clinical
18
TX000045- Dose A + TX000045- Dose B + PlaceboTectonic TherapeuticPhase 2
44
Dose A KER-012 + Dose B KER-012 + Dose C KER-012 + Placebo for 24 Weeks followed by Dose B KER-012 for 72 weeksKeros TherapeuticsPhase 2
44
Tirzepatide + Tirzepatide PlaceboEli LillyApproved
85
L04RD1 + L04TD3CelltrionPhase 1
33
Azilsartan MedoxomilCelltrionPre-clinical
23
AZM X mg + AML Y mg + AZM X mg + AML Y' mg + AZM X' mg + AML Y mg + AZM X' mg + AML Y' mg + AZM X mg + AZM X' mg + AML Y mg + AML Y' mgCelltrionPhase 3
77
Satralizumab (Genetical Recombination)Chugai PharmaceuticalPhase 2
52
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg + Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mgYuhanApproved
85
Telmisartan + Amlodipine + ChlorthalidoneYuhanPhase 1
33
Temisartan/Amlodipine+Rosuvastatin + YHP1604YuhanPhase 1
33
Temisartan+Amlodipine+Rosuvastatin (Combination drug) + Temisartan+Amlodipine + Temisartan+RosuvastatinYuhanPhase 3
77
Amlodipine + ValsartanYuhanApproved
85
Duowell® + TelmisartanYuhanApproved
85
YHP1701 + YHR1703 + YHR1704YuhanPhase 3
77
YH22189 + Twynsta 80/10mg + Crestor 20mgYuhanPhase 1
33
OM 40 + OM/HCTZ 40/12.5Daiichi SankyoPhase 3
77

Other Products from Daiichi Sankyo

Olmesartan medoxomil + Olmesartan medoxomil/hydrochlorothiazide + HydrochlorothiazideApproved
85
OAC aloneApproved
85
Prasugrel + ClopidogrelApproved
85
Diet+pravastatinApproved
85
colesevelam HCl + placeboApproved
85